Author:
Peng Zheng-wu,Xue Fen,Zhou Cui-hong,Zhang Rui-guo,Wang Ying,Liu Ling,Sang Han-fei,Wang Hua-ning,Tan Qing-rong
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference96 articles.
1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442. doi:
10.1371/journal.pmed.0030442
2. Fava M (2003) The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. J Clin Psychiatry 64(Suppl 13):26–29
3. Nemeroff CB (2007) The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 41:189–206. doi:
10.1016/j.jpsychires.2006.05.008
4. Berlim MT, Turecki G (2007) Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 52:46–54
5. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMSCG (2009) Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 120:2008–2039. doi:
10.1016/j.clinph.2009.08.016